Green Thumb Industries Inc. (GTBIF)
(Delayed Data from OTC)
$12.24 USD
-0.26 (-2.08%)
Updated Apr 25, 2024 10:30 AM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Brokerage Reports
0 items in cart
Green Thumb Industries Inc. [GTBIF]
Reports for Purchase
Showing records 1 - 20 ( 123 total )
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: February Performance and Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Strong 4Q Results; Carrying on its Merry(land) Way
Provider: Wedbush Securities Inc.
Analyst: PASCARELLI G
Company: Green Thumb Industries Inc.
Industry: Medical - Products
The Green Machine is Rolling: Results Beat on Record Sales and EBITDA, Improving Cashflow Fuels Buybacks and De-levering.
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Green Thumb Industries Inc.
Industry: Medical - Products
4Q23 Beat Setting the Bar for Sustainable FCF Cash Allocation, $21 PT
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: U.S. Cannabis 4Q23 Earnings Week I
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Capital Remains Tight but Will Flow with Federal Reform Changes
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Cash Flow Key and Rescheduling Look
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Percolating Cannabis Technicals, Trading Volume, Valuations
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: Pressure on DEA to Reschedule After HHS Findings
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
2024 Cannabis Industry Outlook: Resetting and Anticipating Regulatory Catalysts
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: State Led Growth Story to Continue in 2024
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Yearly ReHash: Biggest Developments in Cannabis in 2023
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Green Thumb Industries Inc.
Industry: Medical - Products
Weekly ReHash: New York Set to Expand Adult-use in 2024
Provider: Roth Capital Partners, Inc.
Analyst: Research Department